Top in hem/onc: Gum disease and cancer risk, CAR T-cell therapy
Click Here to Manage Email Alerts
A recent study showed that a history of gum disease may be linked to a higher risk for gastric and esophageal cancers. It was the top story in hematology/oncology last week.
Another top story was about alternatives to chimeric antigen receptor T-cell therapy for patients with cancer.
Read these and more top stories in hematology/oncology below:
Gum disease linked to higher risk for gastric, esophageal cancers
A history of gum disease appeared to be associated with significantly elevated risks for two types of gastrointestinal cancer, according to prospective study results published in Gut. Read more.
Exploring alternatives to CAR T-cell therapy
In this installment of In Practice, Ryan D. Cassaday, MD, explains how to negotiate the delicate balancing act required when discussing alternatives to CAR T-cell therapy with patients and referring colleagues. Read more.
COVID-19 pandemic causing ‘unprecedented disruption’ in cancer research, Fauci says
The COVID-19 pandemic likely will have a significant long-term effect on the diagnosis and treatment of cancer, Anthony S. Fauci, MD, said during an American Association for Cancer Research virtual meeting on COVID-19 and cancer. Read more.
Healthy lifestyles enable survivors to enjoy living instead of fear dying
Survivors of cancer have been given a unique wake-up call to become mindful of their lifestyle habits and make necessary changes. Read more.
AACR forum confronts racism, inequality in research
A session during the American Association for Cancer Research featured several racially and ethnically diverse leaders in the oncology community and focused on the underrepresentation of people of color in clinical trials, academic training programs and leadership positions. Speakers also discussed the disproportionate burden of cancer among historically underrepresented groups. Read more.